/MEDOF
MEDOF Stock - Medios AG
Healthcare|Medical - DistributionOTC
$50.00+0.00%
+$0.00 (+0.00%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.78
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $55.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MEDOF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$49.50 – $50.50
TARGET (TP)$57.50
STOP LOSS$46.00
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.04
52W High$50.00
52W Low$13.64
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.88B | $1.78B | $1.61B | $1.36B | $626.54M |
| Gross Profit | $151.46M | $108.63M | $106.87M | $68.48M | $37.58M |
| Gross Margin | 8.0% | 6.1% | 6.6% | 5.0% | 6.0% |
| Operating Income | $31.66M | $31.37M | $28.97M | $15.26M | $9.54M |
| Net Income | $12.55M | $18.81M | $18.33M | $7.40M | $5.53M |
| Net Margin | 0.7% | 1.1% | 1.1% | 0.5% | 0.9% |
| EPS | $0.51 | $0.79 | $0.77 | $0.37 | $0.36 |
Company Overview
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MEDOFBeat Rate
17%
Last 6 quarters
Avg Surprise
-24.7%
EPS vs Estimate
Beats / Misses
1/5
Last 12 quarters
Latest EPS
$0.33
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q3 24
-48.7%
$0.10vs$0.19
Q4 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
-1.4%
$0.29vs$0.29
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 11, 2025 | — | $0.33 | — | — |
Q3 2025 | Aug 13, 2025 | $0.29 | $0.29 | -1.4% | ✗ MISS |
Q2 2025 | May 13, 2025 | — | $0.25 | — | — |
Q4 2024 | Dec 31, 2024 | — | $0.09 | — | — |
Q4 2024 | Nov 12, 2024 | — | $0.16 | — | — |
Q3 2024 | Aug 13, 2024 | $0.19 | $0.10 | -48.7% | ✗ MISS |
Q2 2024 | May 7, 2024 | — | $0.17 | — | — |
Q4 2023 | Dec 30, 2023 | — | $0.10 | — | — |
Q3 2023 | Sep 30, 2023 | $0.30 | $0.30 | +0.8% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.25 | $0.19 | -25.7% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $0.27 | $0.11 | -59.3% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | — | $0.10 | — | — |
Q4 2022 | Nov 10, 2022 | — | $0.25 | — | — |
Q3 2022 | Aug 11, 2022 | — | $0.21 | — | — |
Q2 2022 | May 11, 2022 | $0.24 | $0.21 | -13.7% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-0.12 | — | — |
Q4 2021 | Nov 9, 2021 | — | $0.17 | — | — |
Q3 2021 | Aug 12, 2021 | — | $0.17 | — | — |
Q2 2021 | May 11, 2021 | — | $0.14 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.11 | — | — |
Latest News
Loading news...
Frequently Asked Questions about MEDOF
What is MEDOF's current stock price?
Medios AG (MEDOF) is currently trading at $50.00 per share. The stock has moved +0.00% today.
What is the analyst price target for MEDOF?
No analyst price targets are currently available for this stock.
What sector is Medios AG in?
Medios AG operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the OTC exchange.
What is MEDOF's market cap?
Medios AG has a market capitalization of $1.28 billion, making it a small-cap company.
Does MEDOF pay dividends?
No, Medios AG does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCMOPF
Cosmo Pharmaceuticals N.V.
$130.61
Mkt Cap: $2.1B
CRWRF
Craneware plc
$26.30
Mkt Cap: $0.9B
EVOTF
Evotec SE
$8.01
Mkt Cap: $1.4B
KSPHF
Kissei Pharmaceutical Co., Ltd.
$26.97
Mkt Cap: $1.1B
LWSCF
Sienna Senior Living Inc.
$15.27
Mkt Cap: $1.4B
MRCHF
H.U. Group Holdings, Inc.
$21.25
Mkt Cap: $1.2B
RAFLF
Raffles Medical Group Ltd
$0.72
Mkt Cap: $1.3B
SWGHF
Sawai Group Holdings Co., Ltd.
$11.52
Mkt Cap: $1.3B
TDVXF
Tobii Dynavox AB (publ)
$10.99
Mkt Cap: $1.2B
TWAPF
Towa Pharmaceutical Co., Ltd.
$16.83
Mkt Cap: $0.8B
Explore stocks similar to MEDOF for comparison